SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-20-022631
Filing Date
2020-11-27
Accepted
2020-11-27 17:25:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 2728767
2 logo_001.jpg GRAPHIC 4599
3 logo_003.jpg GRAPHIC 4599
  Complete submission text file 0001493152-20-022631.txt   2742736
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-248588 | Film No.: 201355933
SIC: 2834 Pharmaceutical Preparations